Deep Track Capital
38 portfolio companies · 6 on the map · $2.5B raised · 6 cities
Portfolio map
6 Deep Track Capital portfolio companies on the map.
Portfolio companies

Ocular Therapeutix
Bedford
Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.
Pharmaceutical Manufacturing$1.2BEst. 2006
Avalo Therapeutics
Chesterbrook
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Biotechnology$606.5MEst. 2011
INOVIO PHARMACEUTICALS
Plymouth Meeting
Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.
Biotechnology Research$579.9M- TB
TORL BioTherapeutics
Culver City
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
Biotechnology Research$96MEst. 2018 Tectonic Therapeutic
Watertown
Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.
BiotechnologyPublicEst. 2019- A
Allakos
Redwood City
Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.
Biotechnology ResearchPublic
More portfolio companies
32 more Deep Track Capital investments we track beyond the map.
GrailMenlo Park · Post-IPO Equity
Maze TherapeuticsSouth San Francisco · Post-IPO Equity
Apogee TherapeuticsSan Francisco · Series B
Oruka TherapeuticsWaltham · Post-IPO Equity
enGeneVancouver · Post-IPO Equity
Ambrosia BiosciencesBoulder · Series B
Terremoto BiosciencesSan Francisco · Series C
Avenzo TherapeuticsSan Diego · Series B
Vigil NeuroscienceCambridge · Series B
Latigo BiotherapeuticsThousand Oaks · Series B
Pyxis OncologyBoston · Post-IPO Equity
Zura BioHenderson · Post-IPO Equity
Halda TherapeuticsNew Haven · Series B
Arbor BiotechnologiesCambridge · Series C
Aligos TherapeuticsSan Francisco · Post-IPO Equity
AltimmuneGaithersburg · Post-IPO Equity
Palisade BioCarlsbad · Post-IPO Equity
Third Harmonic BioCambridge · Series B
Mariana OncologyWatertown · Series B
AnavexNew York · Post-IPO Equity
ValnevaSaint-herblain · Post-IPO Equity
Nurix TherapeuticsSan Francisco · Post-IPO Equity
Inventiva PharmaDaix · Post-IPO Equity
Fate TherapeuticsLa Jolla · Post-IPO Equity
Bicycle TherapeuticsCambridge · Post-IPO Equity
X4 PharmaceuticalsCambridge · Post-IPO Equity
ProMIS NeurosciencesToronto · Post-IPO Equity
Heron TherapeuticsRedwood City · Post-IPO Equity
Regulus TherapeuticsSan Diego · Post-IPO Equity
TricidaMenlo Park · Post-IPO Equity
MindMedNew York · Post-IPO Equity
Magenta TherapeuticsCambridge · Post-IPO Equity
Portfolio map
6 Deep Track Capital portfolio companies on the map.